Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Radient Pharmaceuticals has filed a patent applications for its non-invasive cancer blood test, Onko-Sure, in China and Japan.
Subscribe to our email newsletter
Onko-Sure blood test kit is a 96-well Enzyme-linked immunosorbent assay (ELISA) which is used to detect and treat 19 different types of cancers.
Radient Pharmaceuticals chairman and CEO Douglas MacLellan said Japan and China are larger markets, where having patent protection improves their ability to forge productive distribution partnerships for their cancer test.